Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer (NSCLC) With Brain Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07689721
What this trial is testing

CtDNA-Guided Intraventricular Therapy for CNS Malignancies

Who this might be right for
Leptomeningeal DiseaseGlioblastomaBrain Metastases+2 more
Alireza Mansouri 77
Testing effectiveness (Phase 2)UnknownNCT00614809
What this trial is testing

Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastasis
Guangdong Provincial People's Hospital 45
Early research (Phase 1)Study completedNCT03535363
What this trial is testing

Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC

Who this might be right for
NSCLCNon-small Cell Lung Cancer
Case Comprehensive Cancer Center 6
Early research (Phase 1)Study completedNCT00946673
What this trial is testing

Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Brain CancerNeoplasm MetastasisLung Cancer+1 more
Stanford University 17
Not applicableStudy completedNCT04912128
What this trial is testing

Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC

Who this might be right for
Stereotactic Body Radiation Therapy
Peking University Third Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07234877
What this trial is testing

Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets

Who this might be right for
Non Small Cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 158
Testing effectiveness (Phase 2)Ended earlyNCT00266812
What this trial is testing

Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 35
Not applicableLooking for participantsNCT05864794
What this trial is testing

Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Metastatic
University Medical Center Groningen 100
Large-scale testing (Phase 3)Study completedNCT02831959
What this trial is testing

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Who this might be right for
Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
NovoCure GmbH 298
Testing effectiveness (Phase 2)Active Not RecruitingNCT06020066
What this trial is testing

SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI

Who this might be right for
Brain MetastasesNon-small Cell Lung Cancer
Fudan University 202
Testing effectiveness (Phase 2)UnknownNCT04978753
What this trial is testing

The Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerBrain Metastases
Li-kun Chen 54
Testing effectiveness (Phase 2)UnknownNCT04643847
What this trial is testing

A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases

Who this might be right for
EGFR Positive Non-small Cell Lung CancerBrain Metastases
First People's Hospital of Hangzhou 47
Testing effectiveness (Phase 2)WithdrawnNCT05999357
What this trial is testing

JDQ443 for KRAS G12C NSCLC Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer MetastaticBrain Metastases, AdultKRAS G12C
Maastricht University Medical Center
Early research (Phase 1)Looking for participantsNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT04345146
What this trial is testing

Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT04905550
What this trial is testing

Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Chongqing University Cancer Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT02521051
What this trial is testing

Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Massachusetts General Hospital 11
Testing effectiveness (Phase 2)UnknownNCT02250846
What this trial is testing

Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC

Who this might be right for
Asymptomatic Brain Metastases of Non Small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 70
Large-scale testing (Phase 3)UnknownNCT02338011
What this trial is testing

Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)

Who this might be right for
Non-Small Cell Lung CancerBrain MetastasesEGFR Gene Mutation
Shanghai Chest Hospital 210
Testing effectiveness (Phase 2)Study completedNCT01516983
What this trial is testing

Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

Who this might be right for
Non-small Cell Lung CancerBrain Metastases
Betta Pharmaceuticals Co., Ltd. 15
Next Page